Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-20, Stock:JNJ, The news for the past five days is as follows:
2020-02-12: NEWS1: Johnson & Johnson to Participate in the 9th Annual SVB Leerink Global Healthcare Conference.NEWS2: China Keeps Experts Waiting; Conference Canceled: Virus Update.NEWS3: Buy AbbVie for its Growth Prospects, Yield and Low Valuation.NEWS4: J&J (JNJ) Signs Deal With HHS to Develop Coronavirus Vaccine.NEWS5: The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data.NEWS6: This Medical Giant Is Lingering In A Buy Zone — Are Shares A Good Bet?.
2020-02-13: NEWS1: Dow Jones Today: Coronavirus Controversy Reemerges.NEWS2: 3 Dow Jones Industrial Average Stocks to Sell.
2020-02-14: NEWS1: Dow Jones Today: A Day for Safe Havens.NEWS2: Drug wholesaler stocks falls after WSJ report that states rejected opioid settlement offer.NEWS3: Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails.NEWS4: The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering.
2020-02-18: NEWS1: Health-care stocks hinge on presidential politics — and they’re now looking favorable.NEWS2: Sanofi partners with U.S. agency to develop coronavirus vaccine.NEWS3: Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments.NEWS4: This entrepreneur booked 300% revenue growth in 2 years.
2020-02-19: NEWS1: Why a Top World Stock Fund Likes Microsoft, Alibaba, and Johnson & Johnson.NEWS2: Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs.NEWS3: Sanofi, J&J Join Forces With BARDA for Coronavirus Vaccine.NEWS4: We Wouldn't Be Too Quick To Buy Johnson & Johnson (NYSE:JNJ) Before It Goes Ex-Dividend.

Answer: Decrease